Cabio Biotech (Wuhan) Co., Ltd. (SHA:688089)
20.35
-0.03 (-0.15%)
At close: Jan 23, 2026
3.40% (1Y)
| Market Cap | 3.39B |
| Revenue (ttm) | 596.47M |
| Net Income (ttm) | 169.67M |
| Shares Out | 166.80M |
| EPS (ttm) | 1.01 |
| PE Ratio | 20.15 |
| Forward PE | 18.93 |
| Dividend | 0.20 (0.99%) |
| Ex-Dividend Date | Jul 10, 2025 |
| Volume | 3,822,923 |
| Average Volume | 4,632,097 |
| Open | 20.39 |
| Previous Close | 20.38 |
| Day's Range | 20.24 - 20.45 |
| 52-Week Range | 19.05 - 31.13 |
| Beta | 0.67 |
| RSI | 32.23 |
| Earnings Date | Apr 23, 2026 |